Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDIBANK PRIVATE LIMITED Director's Dealing 2021

May 16, 2021

65365_rns_2021-05-16_65aed3e8-33e5-4184-a168-2ba362a0db43.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [596 x 114] intentionally omitted <==

17 May 2021

Initial Director’s Interest Notice – David Koczkar

In accordance with the Listing Rules, Medibank attaches an Appendix 3X – Initial Director’s Interest Notice for David Koczkar for release to the market.

David Koczkar commenced as CEO and Managing Director of Medibank on 17 May 2021.

This document has been authorised for release by Mei Ramsay, Company Secretary.

Medibank Private Limited ABN 47 080 890 259 GPO Box 9999 Telephone 132 331 medibank.com.au

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Medibank Private Limited
ABN 47 080 890 259

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director David Koczkar
Date of appointment 17 May 2021

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

590,232 performance rights pursuant to the Medibank Private Limited Performance Rights Plan ( Performance Rights ), being:

  • 203,264 Performance Rights granted under the FY19 Long Term Incentive ( LTI );

  • 180,346 Performance Rights granted under the FY20 LTI; and

  • 206,622 Performance Rights granted under the FY21 LTI.

  • See chapter 19 for defined terms.

11/3/2002

Appendix 3X Page 1

Appendix 3X Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

==> picture [401 x 191] intentionally omitted <==

----- Start of picture text -----

Name of holder & nature of Number & class of Securities
interest
Note: Provide details of the circumstances giving rise
to the relevant interest.
Olive Man Investments Pty Ltd
793,689 Ordinary Shares.
----- End of picture text -----

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [406 x 160] intentionally omitted <==

----- Start of picture text -----

Detail of contract
Nature of interest
Name of registered holder
(if issued securities)
No. and class of securities to
which interest relates
----- End of picture text -----

  • See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002